{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:00:42Z","timestamp":1768975242458,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd001073","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,9,3]],"date-time":"2013-09-03T00:00:00Z","timestamp":1378166400000}}],"reference-count":56,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001073.pub2","type":"journal-article","created":{"date-parts":[[2013,9,3]],"date-time":"2013-09-03T19:56:22Z","timestamp":1378238182000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["D-Penicillamine for preventing retinopathy of prematurity in preterm infants"],"prefix":"10.1002","volume":"2013","author":[{"given":"Mosarrat J","family":"Qureshi","sequence":"first","affiliation":[{"name":"Royal Alexandra Hospital, University of Alberta; Pediatrics; Edmonton Alberta Canada T5H 3V9"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[{"name":"University of Alberta; Department of Pediatrics; Edmonton Alberta Canada T5H 3V9"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,9,3]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD001073.pub2-BIB0001|cit1","first-page":"47","article-title":"Controlled trial of D-penicillamine to prevent retinopathy of prematurity","volume":"27","author":"Lakatos","year":"1986","journal-title":"Acta Paediatrica Hungary"},{"issue":"1","key":"10.1002\/14651858.CD001073.pub2-BIB0002|cit2","first-page":"9","article-title":"One year longitudinal follow-up of premature infants treated with D-penicillamine in the neonatal period","volume":"28","author":"Vekerdy-Lakatos","year":"1987","journal-title":"Acta Paediatrica Hungary"},{"key":"10.1002\/14651858.CD001073.pub2-BIB0003|cit3","first-page":"9","article-title":"Controlled trial of use of D-penicillamine to prevent retinopathy of prematurity in very low-birth-weight infants","volume-title":"Physiologic Foundations of Perinatal Care","volume":"2","author":"Lakatos","year":"1987"},{"issue":"9","key":"10.1002\/14651858.CD001073.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/j.1651-2227.2010.01837.x","article-title":"Oral D-penicillamine for the prevention of retinopathy of prematurity in very low birth weight infants: a randomised, placebo-controlled trial","volume":"99","author":"Tandon","year":"2010","journal-title":"Acta Paediatrica"},{"issue":"2","key":"10.1002\/14651858.CD001073.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/sj.jp.7211440","article-title":"A pilot trial testing the feasibility of administering D-penicillamine to extremely low birth weight neonates","volume":"26","author":"Christensen","year":"2006","journal-title":"Journal of Perinatology"},{"issue":"2","key":"10.1002\/14651858.CD001073.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/sj.jp.7211653","article-title":"D-Penicillamine administration and the incidence of retinopathy of prematurity","volume":"27","author":"Christensen","year":"2007","journal-title":"Journal of Perinatology"},{"issue":"1","key":"10.1002\/14651858.CD001073.pub2-BIB0007|cit7","first-page":"9","article-title":"Is the treatment of prematurely born infants with D-penicillamine decreasing the frequency of retrolental fibroplasia? [In Hungarian]","volume":"117","author":"Lakatos","year":"1980","journal-title":"Szemeszet Ophthalmologica Hungarica"},{"key":"10.1002\/14651858.CD001073.pub2-BIB0010|cit8","first-page":"355","article-title":"Antioxidant effects of d-penicillamine in the neonatal period","volume":"16","author":"Lakatos","year":"1982","journal-title":"Magyar Pediater"},{"issue":"2","key":"10.1002\/14651858.CD001073.pub2-BIB0008|cit9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00441157","article-title":"Prevention of retrolental fibroplasia in very low birth weight infants by D penicillamine","volume":"138","author":"Lakatos","year":"1982","journal-title":"European Journal of Pediatrics"},{"key":"10.1002\/14651858.CD001073.pub2-BIB0009|cit10","first-page":"525","article-title":"Prevention of retrolental fibroplasia with D-penicillamine [In Hungarian]","volume":"32","author":"Lakatos","year":"1981","journal-title":"Gyermekgyogyaszat"},{"issue":"4","key":"10.1002\/14651858.CD001073.pub2-BIB0011|cit11","first-page":"459","article-title":"Neonatal oxygen toxicity and its prevention:\u00a0D-penicillamine\u00a0offers benefits without harmful side-effects","volume":"23","author":"Oroszl\u00e1n","year":"1982","journal-title":"Acta Paediatrica Academiae Scientiarum Hungaricae"},{"issue":"4","key":"10.1002\/14651858.CD001073.pub2-BIB0012|cit12","first-page":"327","article-title":"D-penicillamine in the prevention of retrolental fibroplasia","volume":"23","author":"Lakatos","year":"1982","journal-title":"Acta Paediatrica Academiae Scientiarum Hungaricae"},{"issue":"5","key":"10.1002\/14651858.CD001073.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0002-9394(14)77389-1","article-title":"Penicillamine, vitreous proliferation, and\u00a0retinopathy\u00a0of prematurity","volume":"93","author":"Lakatos","year":"1982","journal-title":"American Journal Ophthalmology"},{"key":"10.1002\/14651858.CD001073.pub2-BIB0014|cit14","first-page":"293","article-title":"Clinical observations in the prevention of retrolental fibroplasia with D-penicillamine","volume-title":"Physiologic Foundations of Perinatal Care","author":"Lakatos","year":"1985"},{"issue":"6","key":"10.1002\/14651858.CD001073.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1542\/peds.82.6.951a","article-title":"D-penicillamine and retinopathy of prematurity [letter]","volume":"82","author":"Lakatos","year":"1988","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001073.pub2-BIB0016|cit16","first-page":"188","article-title":"D-penicillamine in the neonatal period","volume-title":"Physiologic Foundations of Perinatal Care","author":"Lakatos","year":"1989"},{"issue":"10","key":"10.1002\/14651858.CD001073.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/archopht.1996.01100140452016","article-title":"Vascular endothelial growth factor and the eye - past, present, and future","volume":"114","author":"Aiello","year":"1996","journal-title":"Archives of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD001073.pub2-BIB0018|cit18","first-page":"1647","article-title":"Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies","volume":"38","author":"Aiello","year":"1997","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"5","key":"10.1002\/14651858.CD001073.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1542\/peds.2006-0349","article-title":"2005 American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: neonatal resuscitation guidelines","volume":"117","author":"\u00a0American\u00a0Academy of","year":"2006","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001073.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"e1483","DOI":"10.1542\/peds.2009-2218","article-title":"High or low oxygen saturation and severe retinopathy of prematurity: a meta-analysis","volume":"125","author":"Chen","year":"2010","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001073.pub2-BIB0021|cit21","unstructured":"Soll RF Bracken MB Horbar JD Ohlsson A Suresh G Haughton DE Cochrane Neonatal Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs) NEONATAL 2011"},{"issue":"1","key":"10.1002\/14651858.CD001073.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001073","article-title":"D-Penicillamine for preventing retinopathy of prematurity in preterm infants","author":"Phelps","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD001073.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1001\/archopht.1990.01070120056029","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome - structure and function","volume":"108","author":"Cryotherapy for Retinopathy of Prematurity Cooperative Group","year":"1990","journal-title":"Archives of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD001073.pub2-BIB0024|cit24","first-page":"580","article-title":"D-penicillamine in early rheumatoid arthritis","volume":"15","author":"Drosos","year":"1997","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD001073.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0161-6420(87)33400-1","article-title":"Retinopathy of prematurity: a randomised, prospective trial of transcutaneous oxygen monitoring","volume":"94","author":"Flynn","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD001073.pub2-BIB0026|cit26","first-page":"233-8; discussi","article-title":"Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomised trial","volume":"102","author":"Good","year":"2004","journal-title":"Transactions of the American Ophthalmological Society"},{"issue":"26","key":"10.1002\/14651858.CD001073.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001073.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The\u00a0Cochrane\u00a0Collaboration's\u00a0tool\u00a0for\u00a0assessing\u00a0risk of\u00a0bias\u00a0in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD001073.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1399-3011.1993.tb00139.x","article-title":"Control of peptide disulfide regioisomer formation by mixed cysteine-penicillamine bridges","volume":"42","author":"Hunt","year":"1993","journal-title":"International Journal of Peptide and Protein Research"},{"issue":"8","key":"10.1002\/14651858.CD001073.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archopht.1984.01040030908011","article-title":"The Committee for the Classification of Retinopathy of Prematurity","volume":"102","author":"An International Committee for the Classification of Retinopathy of Prematurity","year":"1984","journal-title":"Archives of Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD001073.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity revisited","volume":"123","author":"An International Committee for the Classification of Retinopathy of Prematurity","year":"2005","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD001073.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archopht.1956.00930040489001","article-title":"Retrolental fibroplasia: cooperative study of retrolental fibroplasia and the use of oxygen","volume":"56","author":"Kinsey","year":"1956","journal-title":"Archives of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD001073.pub2-BIB0033|cit33","first-page":"9","article-title":"D-Penicillamine treatment of hyperbilirubinaemia in preterm infants","volume":"19","author":"Koranyi","year":"1978","journal-title":"Acta Paediatrica Academiae Scientiarum Hungaricae"},{"issue":"1","key":"10.1002\/14651858.CD001073.pub2-BIB0034|cit34","first-page":"90","article-title":"Bioavailability\u00a0and pharmacokinetics of\u00a0D-penicillamine","volume":"10","author":"Kukovetz","year":"1983","journal-title":"Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD001073.pub2-BIB0035|cit35","first-page":"93","article-title":"D-Penicillamine therapy in neonatal jaundice: comparison with phototherapy","volume":"17","author":"Lakatos","year":"1976","journal-title":"Acta Paediatrica Academiae Scientiarum Hungaricae"},{"issue":"2","key":"10.1002\/14651858.CD001073.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00442643","article-title":"D-Penicillamine therapy in ABO haemolytic disease of the newborn infant","volume":"123","author":"Lakatos","year":"1976","journal-title":"European Journal of Pediatrics"},{"key":"10.1002\/14651858.CD001073.pub2-BIB0037|cit37","first-page":"Abstract 3165","article-title":"Plasma level of vascular endothelial growth factor in retinopathy of prematurity after intravitreal injection of bevacizumab","volume":"52","author":"Lee","year":"2011","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"1","key":"10.1002\/14651858.CD001073.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1172\/JCI113853","article-title":"Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine","volume":"83","author":"Matsubara","year":"1989","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD001073.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/bjo.2008.156810","article-title":"Plasma levels of vascular endothelial growth factor and pigment epithelium derived factor before and after intravitreal injection of bevacizumab","volume":"94","author":"Matsuyama","year":"2010","journal-title":"British Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD001073.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1006\/exer.1994.1133","article-title":"Prevention of collagen crosslinking increases form-deprivation myopia in tree shrew","volume":"59","author":"McBrien","year":"1994","journal-title":"Experimental Eye Research"},{"issue":"7","key":"10.1002\/14651858.CD001073.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Ef\ufb01cacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD001073.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0161-6420(91)32074-8","article-title":"The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Incidence and early course of retinopathy of prematurity","volume":"98","author":"Palmer","year":"1991","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD001073.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000122","article-title":"Early light reduction to prevent retinopathy of prematurity in very low birth weight infants","author":"Phelps","year":"1997","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"21","key":"10.1002\/14651858.CD001073.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"7177","DOI":"10.1021\/bi00021a032","article-title":"Role of thiols in the targeting of S-nitroso thiols to red blood cells","volume":"34","author":"Pietraforte","year":"1995","journal-title":"Biochemistry"},{"issue":"3","key":"10.1002\/14651858.CD001073.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/ajmg.a.10871","article-title":"Infant with severe penicillamine embryopathy born to a woman with Wilson disease","volume":"128A","author":"Pinter","year":"2004","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"6","key":"10.1002\/14651858.CD001073.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0022-3476(97)70031-3","article-title":"Vitamin E prophylaxis to reduce retinopathy of prematurity - a reappraisal of published trials","volume":"131","author":"Raju","year":"1997","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD001073.pub2-BIB0047|cit47","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"5","key":"10.1002\/14651858.CD001073.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1515\/jpme.1995.23.5.385","article-title":"D-penicillamine inhibits the action of reactive oxygen species in the pig pulmonary circulation","volume":"23","author":"Sanderud","year":"1995","journal-title":"Journal of Perinatal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001073.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity","volume":"153","author":"Sato","year":"2012","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD001073.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1203\/00006450-198406000-00002","article-title":"Hypoxanthine and oxygen induced lung injury: a possible basic mechanism of tissue damage?","volume":"18","author":"Saugstad","year":"1984","journal-title":"Pediatric Research"},{"issue":"2","key":"10.1002\/14651858.CD001073.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/bbrc.1996.0730","article-title":"Expression of biologically active isoforms of the tumour angiogenesis factor VEGF in Escherichia coli","volume":"222","author":"Siemeister","year":"1996","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10.1002\/14651858.CD001073.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1755-3768.2011.02351.x","article-title":"Time to consider a new treatment protocol for aggressive posterior retinopathy of prematurity?","volume":"91","author":"Spandau","year":"2012","journal-title":"Acta Ophthalmologica"},{"issue":"8","key":"10.1002\/14651858.CD001073.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1056\/NEJM198408233110817","article-title":"Scavenging of hydrogen peroxide - a new mechanism of action for D-penicillamine in rheumatoid arthritis","volume":"311","author":"Staite","year":"1984","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001073.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1542\/peds.105.2.295","article-title":"Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomised, controlled trial. I: primary outcomes","volume":"105","author":"STOP-ROP Multicenter Trial","year":"2000","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001073.pub2-BIB0055|cit55","first-page":"9","article-title":"One year longitudinal follow up of premature infants treated with D-Penicillamine in the neonatal period","volume":"28","author":"Vekerdy-Lakatos","year":"1987","journal-title":"Acta Paediatrica Hungarica"},{"issue":"2","key":"10.1002\/14651858.CD001073.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1227\/00006123-199508000-00014","article-title":"Copper chelation inhibits tumour angiogenesis in the experimental 9L gliosarcoma model","volume":"37","author":"Yoshida","year":"1995","journal-title":"Neurosurgery"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001073.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T09:17:11Z","timestamp":1728292631000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001073.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neonatal Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,3]]},"references-count":56,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001073.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,3]]}}}